{"id":"https://openalex.org/W7213279646","doi":"https://doi.org/10.1186/s12885-026-17335-x","title":"Metabolic\u2013clinical subtypes predict survival in BCLC-C hepatocellular carcinoma receiving synchronous TACE plus targeted and immunotherapy","display_name":"Metabolic\u2013clinical subtypes predict survival in BCLC-C hepatocellular carcinoma receiving synchronous TACE plus targeted and immunotherapy","publication_year":2026,"publication_date":"2026-11-12","ids":{"openalex":"https://openalex.org/W7213279646","doi":"https://doi.org/10.1186/s12885-026-17335-x"},"language":"en","primary_location":{"id":"doi:10.1186/s12885-026-17335-x","doi":"https://doi.org/10.1186/s12885-026-17335-x","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12885-026-17335-x","pdf_url":null,"source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1186/s12885-026-17335-x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009223437","display_name":"Liqing Li","orcid":"https://orcid.org/0000-0002-2987-0259","observed_orcids":["https://orcid.org/0000-0002-2987-0259"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Liqing Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5151820597","display_name":"Zhitao Lin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhitao Lin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100776246","display_name":"Junbao Wei","orcid":"https://orcid.org/0000-0003-2302-3128","observed_orcids":["https://orcid.org/0000-0003-2302-3128"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Junbao Wei","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3390,"currency":"USD","value_usd":3390},"apc_paid":{"value":3390,"currency":"USD","value_usd":3390},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9819999933242798},{"id":"https://openalex.org/keywords/metabolic-phenotypes","display_name":"metabolic phenotypes","score":0.796999990940094},{"id":"https://openalex.org/keywords/metabolic-fitness","display_name":"metabolic fitness","score":0.7160000205039978},{"id":"https://openalex.org/keywords/triple-therapy","display_name":"triple therapy","score":0.550000011920929},{"id":"https://openalex.org/keywords/transarterial-chemoembolization","display_name":"transarterial chemoembolization","score":0.9279999732971191},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9100000262260437},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9909999966621399},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7089999914169312},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8029999732971191},{"id":"https://openalex.org/keywords/metabolic-subtypes","display_name":"metabolic subtypes","score":0.5680000185966492}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6510000228881836},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.6176000237464905},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.6057000160217285},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.5817000269889832},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5698000192642212},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5573999881744385},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.5232999920845032},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5016000270843506},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.4456999897956848},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.435699999332428},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4023999869823456},{"id":"https://openalex.org/C73555534","wikidata":"https://www.wikidata.org/wiki/Q622825","display_name":"Cluster analysis","level":2,"score":0.38089999556541443},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.3580999970436096},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3424000144004822},{"id":"https://openalex.org/C164465091","wikidata":"https://www.wikidata.org/wiki/Q7248371","display_name":"Prognostic variable","level":3,"score":0.3345000147819519},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.33219999074935913},{"id":"https://openalex.org/C161584116","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate statistics","level":2,"score":0.31540000438690186},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3084999918937683},{"id":"https://openalex.org/C63479239","wikidata":"https://www.wikidata.org/wiki/Q7353546","display_name":"Robustness (evolution)","level":3,"score":0.30160000920295715},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.2928999960422516},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.267300009727478},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.2605000138282776},{"id":"https://openalex.org/C77350462","wikidata":"https://www.wikidata.org/wiki/Q1125472","display_name":"Confounding","level":2,"score":0.25540000200271606},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.2540000081062317},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.25130000710487366}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1186/s12885-026-17335-x","doi":"https://doi.org/10.1186/s12885-026-17335-x","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12885-026-17335-x","pdf_url":null,"source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},{"id":"doi:10.21203/rs.3.rs-10801004/v1","doi":"https://doi.org/10.21203/rs.3.rs-10801004/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-10801004/v1","pdf_url":"https://www.researchsquare.com/article/rs-10801004/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1186/s12885-026-17335-x","doi":"https://doi.org/10.1186/s12885-026-17335-x","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12885-026-17335-x","pdf_url":null,"source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7213279646.pdf","grobid_xml":"https://content.openalex.org/works/W7213279646.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4315478057","https://openalex.org/W4415884724","https://openalex.org/W4313003606","https://openalex.org/W4292291670","https://openalex.org/W4281285997","https://openalex.org/W4388518699","https://openalex.org/W3169629560","https://openalex.org/W4390233607","https://openalex.org/W4402125866","https://openalex.org/W3000701846"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"The":[2,164,213],"synchronous":[3,35,99,228],"combination":[4],"of":[5,45,88,201],"TACE,":[6],"TKIs,":[7],"and":[8,54,67,120,158],"ICIs":[9],"has":[10],"improved":[11,103],"outcomes":[12],"for":[13],"patients":[14,47,219],"with":[15,48,64,76,107,220],"BCLC-C":[16,49,221],"HCC,":[17],"yet":[18],"treatment":[19],"response":[20,33],"varies":[21],"widely.":[22],"This":[23],"study":[24,44],"aimed":[25],"to":[26,34,70,84,225],"identify":[27],"metabolically":[28,143,148,159,165,180,203],"distinct":[29,140],"phenotypes":[30],"that":[31,197,232],"predict":[32],"triple":[36,100,229],"therapy.":[37],"Methods":[38],"We":[39],"conducted":[40,80],"a":[41,184],"retrospective":[42],"cohort":[43],"1,792":[46],"HCC.":[50],"Propensity":[51],"score":[52,95],"matching":[53,96],"L2-penalized":[55],"multivariate":[56],"Cox":[57],"regression":[58],"were":[59,79,131],"performed,":[60],"followed":[61],"by":[62],"XGBoost":[63],"SHAP":[65],"transformation":[66],"K-means":[68,136],"clustering":[69,90,137,216],"define":[71],"metabolic":[72,119,141,214],"subtypes.":[73],"Subgroup":[74,194],"analyses":[75,195],"interaction":[77],"testing":[78],"across":[81,208],"clinical":[82,121,210],"strata":[83],"validate":[85],"the":[86,89,179,198,202],"robustness":[87],"system.":[91],"Results":[92],"After":[93],"propensity":[94],"(716":[97],"pairs),":[98],"therapy":[101],"significantly":[102],"overall":[104],"survival":[105,170],"compared":[106],"pre-immunotherapy":[108],"TACE":[109],"(median,":[110],"28.0":[111],"vs.":[112],"8.0":[113],"months;":[114,174,190],"P":[115],"<":[116],"0.001).":[117],"Eight":[118],"factors":[122],"(AFP,":[123],"TP,":[124],"GGT,":[125],"LDH,":[126],"P,":[127],"metastasis,":[128],"HCO3,":[129],"RBC)":[130],"identified":[132],"as":[133],"independent":[134],"predictors.":[135],"resolved":[138],"four":[139],"phenotypes:":[142],"fit":[144,166,204],"(Cluster":[145,150,155,161],"1,":[146],"58.5%),":[147],"compensated":[149],"2,":[151],"24.6%),":[152],"tumor-metabolism":[153],"dominant":[154],"3,":[156],"14.5%),":[157],"exhausted":[160,181],"4,":[162],"2.4%).":[163],"phenotype":[167,182,205],"demonstrated":[168],"exceptional":[169],"(median":[171,187],"OS,":[172,176,188,192],"38.0":[173],"1-year":[175,191],"82.7%),":[177],"while":[178],"showed":[183],"dismal":[185],"prognosis":[186,200],"4.0":[189],"4.2%).":[193],"confirmed":[196],"favorable":[199],"remained":[206],"consistent":[207],"all":[209],"strata.":[211],"Conclusions":[212],"fitness-based":[215],"framework":[217],"identifies":[218],"HCC":[222],"most":[223],"likely":[224],"benefit":[226],"from":[227],"therapy,":[230],"suggesting":[231],"routine":[233],"laboratory":[234],"tests":[235],"may":[236],"help":[237],"guide":[238],"precision":[239],"patient":[240],"selection.":[241]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-09-16T00:00:00"}